Growth Hormone in EB

Cairo University50 enrolled

Overview

Growth is extremely affected in epidermolysis bullosa patients

Studying the role of growth hormone and ILGF-1 in EB may pave the to new therapeutic modality that could improve the growth in those children and avoid the irreversible sequelae that affected subjects experience after adulthood

Study Type

OBSERVATIONAL

Enrollment

Conditions

Epidermolysis Bullosa Dystrophica

Interventions

growth hormone level and insulin like growth factor 1DIAGNOSTIC_TEST

laboratory test

Eligibility

Sex: ALLMin age: 1 MonthMax age: 12 Years

Medical Language ↔ Plain English

Inclusion Criteria: \- Children with EB dystrophica Exclusion Criteria: * Adults with the same disease

Outcomes

Primary Outcomes

level of growth hormone and insulin like growth factor 1

laboratory test

Time frame: 2 weeks

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.